Cardiac function in 5-year survivors of childhood cancer: A long-term follow-up study

Keyphrases

• Cardiotoxicity 100%
• 5-year Survivors 100%
• Cardiac Function 100%
• Shortening Fraction 100%
• Anthracyclines 80%
• Ifosfamide 40%
• Daunorubicin 40%
• Age at Diagnosis 40%
• Young Age 40%
• High-dose Cyclophosphamide 40%
• Subclinical Cardiac Dysfunction 40%
• Cardiac Irradiation 40%
• Tumor 20%
• Older Adults 20%
• Left Ventricular Dysfunction 20%
• Echocardiogram 20%
• Doxorubicin 20%
• Late Effects 20%
• Non-associated 20%
• Large Cohort 20%
• Regression Analysis 20%
• Strong Predictor 20%
• Logistic Regression Analysis 20%
• Echocardiography 20%
• Thorax 20%
• Mortality Risk 20%
• Outpatient Clinic 20%
• Left Ventricular Function 20%
• Hydrochloride 20%
• Epirubicin Hydrochloride 20%
• Vincristine Sulfate 20%
• Multivariate Linear Regression Model 20%
• Morbidity Risk 20%
• Treatment Data 20%

Medicine and Dentistry

• Childhood Cancer 100%
• Heart Function 100%
• Anthracycline 57%
• Drug Megadose 42%
• Echocardiography 28%
• Cyclophosphamide 28%
• Ifosfamide 28%
• Linear Regression Analysis 28%
• Liposomal Daunorubicin 28%
• Neoplasm 14%
• Heart Left Ventricle Failure 14%
• Prevalence 14%
• Cohort Analysis 14%
• Doxorubicin 14%
• Epirubicin 14%
• Late Effect 14%
• Logistic Regression Analysis 14%
• Outpatient 14%
• Morbidity 14%
• Chest 14%
• Vincristine Sulfate 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Childhood Cancer 100%
• Anthracycline 57%
• Cyclophosphamide 28%
• Ifosfamide 28%
• Daunorubicin 28%
• Neoplasm 14%
• Heart Left Ventricle Failure 14%
• Doxorubicin 14%
• Epirubicin 14%
• Cohort Study 14%
• Prevalence 14%
• Vincristine Sulfate 14%
• Morbidity 14%